Younger Postmenopausal Patients With Early-stage Breast Cancer May Be Able to Safely Omit Adjuvant Radiotherapy
Results are from a five-year follow-up; long-term study is needed SAN ANTONIO โ Almost all postmenopausal patients aged 50-69...
Results are from a five-year follow-up; long-term study is needed SAN ANTONIO โ Almost all postmenopausal patients aged 50-69...
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA โ Of the 198 new...
Study highlights potential benefits of broadening eligibility criteria for clinical trials PHILADELPHIA โ Patients with treatment-refractory cancers who received...
NEW ORLEANS โ The accuracy of prostate-specific antigen (PSA) screening for prostate cancer could be improved by accounting for...
PHILADELPHIA โ The American Association for Cancer Research (AACR) will honor Elizabeth M. Jaffee, MD, Fellow of the AACR...
“SAN ANTONIO – Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates...
SAN ANTONIO โ Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK)...
SAN ANTONIO โ The addition of the anti-PD-1 immunotherapeutic pembrolizumab (Keytruda) to neoadjuvant chemotherapy increased the rates of pathologic complete response (pCR)...
NEW ORLEANS – A culturally tailored multilevel strategy designed to remove barriers to human papillomavirus (HPV) vaccination among low-income,...
“SAN ANTONIO – Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after...
Test employs error correction to increase accuracy PHILADELPHIA – A new liquid biopsy test could detect microsatellite instability (MSI)...
SAN ANTONIO โ A large meta-analysis of breast cancer patients showed that residual cancer burden after neoadjuvant chemotherapy is...
PHILADELPHIA – The American Association for Cancer Research (AACR) and the Lung Cancer Initiative at Johnson & Johnson (LCI)...
PHILADELPHIA โ Today, the American Association for Cancer Research (AACR) released the 12th edition of its annual Cancer Progress...
PHILADELPHIA โ Today, the American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19...
PHILADELPHIA – June 12, 2019 – Stand Up To Cancer (SU2C) with its Scientific Partner, the American Association for...
Article provides timely information following new law that will require trial sponsors to submit Diversity Action Plans to FDA...
The project will further enhance a unique, real-world clinico-genomic dataset through the joint efforts of nine biopharmaceutical companies PHILADELPHIA...
“The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded...
PHILADELPHIA โ The American Association for Cancer Research (AACR) announced today that Elaine S. Jaffe, MD, will receive the...
Among those recognized are 19 members of the AACR PHILADELPHIA – The American Association for Cancer Research (AACR) congratulates...
Awardees to be recognized at the virtual AACR Annual Meeting 2021 PHILADELPHIA โ The American Association for Cancer Research...
PHILADELPHIA โ The American Association for Cancer Research (AACR) today announced the formation of its seventh and newest scientific...
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA โ The American Association for Cancer Research (AACR) is inviting journalists...
Symptoms were associated with lower mental quality of life for both Black and white patients LOS ANGELES โ Among...
Among patients who received immunotherapy, outcomes were similar between Black and white patients LOS ANGELES โ In recent years,...
LOS ANGELES โ The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white...
SAN DIEGO โ Accelerated aging was more common in recent birth cohorts and was associated with increased incidence of...
The investigational therapy uses a cold-temperature probe to kill a portion of prostate cancer cells and release tumor-specific neoantigens...
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...